School of Medicine
Showing 81-90 of 99 Results
-
Edith Vioni Sullivan
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsApplication of neuroimaging modalities and component process analysis of cognitive, sensory, and motor functions to identify brain structural and functional mechanisms disrupted in diseases affecting the brain: alcohol use disorder, HIV infection, dementia, and normal aging from adolescence to senescence.
-
Leonardo Tozzi
Research Engineer, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioLeonardo Tozzi, M.D., Ph.D., graduated as a Medical Doctor from Pisa University and Sant'Anna School of Advanced Studies in 2013. In 2018, he was awarded his Ph.D. from Trinity College Dublin for his research on the impact of genetic risk factors, epigenetic modifications and environmental stressors on structural and functional brain changes related to depression.
Leonardo joined Stanford in 2018 as a post-doctoral researcher working within the framework of the Human Connectome Project. Since 2022, he leads the Computational Neuroscience & Neuroimaging Program at the Stanford Center for Precision Mental Health and Wellness.
The goal of Leonardo's research is to develop quantitative biomarkers for psychiatry that are reliable, interpretable and can be used to guide treatment selection and estimate therapy response. To this end, he integrates behavioral measures and symptoms with large scale recordings of brain structure and function as well as other biological markers.
In his free time, Leonardo enjoys practicing martial arts, playing video-games, learning philosophy and discovering the local culture. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
On Leave from 10/01/2021 To 08/31/2022Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
Pablo Villoslada
Adjunct Professor, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioPablo Villoslada received his MD at the University of Santiago de Compostela (Spain) in 1990. He completed the speciality in neurology in 1995 at the Hospital Vall d’Hebron (Spain) and the PhD in Neuroimmunology in 1996 at the Autonomous University of Barcelona (Spain). He moved to the University of California, San Francisco (US) as a postdoctoral fellow returning to Barcelona in 1998 and he worked as Assistant Professor of the University of Navarra from 2001 to 2008. He became Group leader of the Neuroimmunology group of the Institute of Biomedical Research August Pi Sunyer (IDIBAPS) – Hospital Clinic - University of Barcelona, Spain, in 2009. From 2014 to 2017 he became Adjunct Professor at the Department of Neurology at the University of California, San Francisco. From 2017 to 2018 he worked a Medical Director of Neuroinflammation at Genentech. Since October 2018 is adjunct professor at Stanford University. He is a serial entrepreneur, having founded Health Engineering (imaging software) and Bionure (drug development CNS), and being venture partner with Alta Life Sciences and Spire Bioventure. He joined the neurosciences team at Stanford University in October 2018.
Pablo Villoslada has been active in the Neurosciences and brain diseases research for more than 20 years contributing to the application of systems biology to neurological diseases, development of new therapies or biomarkers for Multiple Sclerosis and neurodegenerative diseases, and developing new neuroimaging technologies for monitoring brain diseases. He has published more than 170 scientific articles in journals in the field of neurology and has been granted 9 patents in biomarkers and new therapies for brain diseases. He has also obtained 5 EU grants and several others from international foundations. -
Jessica Paige Watson
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioJessica Watson is a fourth-year Clinical Psychology PhD student at Palo Alto University with an emphasis in Neuropsychology. She is currently a neuropsychological assessor through Stanford's Brain Development Project, conducting behavioral and cognitive testing for research projects. Prior to this, Jessica was a Research Assistant at the Stanford Center for Neuroscience in Women's Health. Jessica belongs to the BRAIN lab at Palo Alto University. Her most recent research involves the lab’s pediatric sport concussion program, examining the frequency of “abnormal” (i.e., low) scores in baseline tests of healthy youth to differentiate between statistical and clinical significance. She is working towards completing her dissertation, which examines the level of consensus across psychologists regarding assessment practices.
